SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-081937
Filing Date
2024-07-08
Accepted
2024-07-08 06:40:09
Documents
14
Period of Report
2024-07-03
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ktra-20240703.htm   iXBRL 8-K 90521
2 EX-99.1 ktra-ex99_1.htm EX-99.1 46561
3 GRAPHIC img40499469_0.jpg GRAPHIC 90379
4 GRAPHIC img40499469_1.jpg GRAPHIC 5490
  Complete submission text file 0000950170-24-081937.txt   408313

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ktra-20240703.xsd EX-101.SCH 30542
16 EXTRACTED XBRL INSTANCE DOCUMENT ktra-20240703_htm.xml XML 4689
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 241103322
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)